Ubiquinone Market size will witness significant growth with increased application in food, cosmetic and medicine industry.

Ubiquinone Market size will witness significant growth with increased application in food, cosmetic and medicine industry. Demand has risen globally with increase in health consciousness and benefits of using the product in herbal sectors. It is used in medicine industry for treatment of low blood pressure, migraine headache, Parkinson’s disease, dental disease and cancer. Further, it is used as substitute in medicine for treating coenzyme deficiency and expected to propel ubiquinone market.

Ubiquinol is an oxidant that reduces body’s aging phenomenon naturally. As an antioxidant, it finds application in cosmetics and personal care products. It is naturally found in organ meat, fish, and whole grains and used in food supplements. Surge in consumption of food supplements with increase in aging population and inclination of people towards healthy lifestyle is anticipated to propel ubiquinone market.

Ubiquinone or coenzyme Q10, ubidecarenone & ubiquinol are naturally produced in body and found in animals, plants, aerobic organisms and bacteria. These are fat soluble substances that resemble vitamin and found in eukaryotic cells primarily in mitochondria. Ubiquinol is found in organs that require high energy comprising of heart, kidney and liver. Coenzyme Q10 is present in three redox states namely ubiquinone (fully oxidized), semi quinone and ubiquinol (fully reduced).

Ask for Table of Content this report @ https://www.gminsights.com/request-toc/upcoming/1960

The product’s deficiency may lead to reduced biosynthesis and it is used for the treatment of Huntington’s disease, male infertility, cancer, statin myopathy. Its use supports nervous system, boosts the immune system and produces more energy for cells. Further, these help in skin rejuvenation and a source of antioxidant, that in turn propel ubiquinone market growth.

Major restraint for ubiquinone market is its high fabrication cost. Its high dosage can cause low blood pressure, skin rash, loss of appetite and nausea. These issues may restrict product growth. However, undergoing research to discover cost effective methods for its manufacturing will neutralize its effect.

Ubiquinone is used in different applications including, food, medicine and cosmetic industry. Food industry has major share owing to its use in supplementary products. Demand for coenzyme Q10 has grown with increase in fitness centres and health clubs. Sports nutrition has inflated due to health benefits. Global supplement sector was valued at USD 132.8 billion in 2016 and is expected to grow at around 8% in the forecast period, that in turn will increase ubiquinone market size.

Its requirement in medical industry has surged with utilization in pharmaceutical products and medicines for treatment of various diseases. There has been an advancement in medical sciences that has improved the use of coenzyme Q10. Cosmetic industry has seen a rise with increasing aging population as it is used for reducing fine lines, wrinkles and to provide refreshed skin. Further, based on ingredients, dietary supplements containing ubiquinol can be classified into botanicals, vitamins, minerals and amino acids.

The product is processed in diverse ways including, microbial fermentation, chemical synthesis and extraction from biological tissues. Microbial fermentation is widely used for ubiquinol processing as it is environment friendly. In this, microbes are used to produce coenzyme Q10 as fermentation biocatalysts and optimizing fermentation process to meet regulation requirements. In chemical synthesis process, coenzyme acts as redox enzyme in eukaryotic and prokaryotic cells that helps in identification of ubiquinol binding proteins. Its extraction from biological tissues is under development.

Asia Pacific has significant share in global ubiquinone market owing to growing awareness about dietary supplements benefit and product availability. The industry is expected to grow further with the increase in disposable income and use of health care products. North America, led by the U.S. has substantial share due to growing obesity problems and aged people. Growing risk of life threatening diseases among geriatric population and consumers opting for food supplements will drive ubiquinone market.

Europe has moderate share in ubiquinone market with consumers switching towards a healthy life style. Further, theregion has substantial share in cosmetics industry that has enhanced coenzyme Q10 usage. Latin America and Middle East & Africa are will foresee moderate growth with rise in urban population and increasing retail channels.

Ubiquinone market is moderately consolidated with the presence of few companies in the industry holding significant share. Some of the key players for ubiquinone market are Kaneka Corporation, Captek, MGC Pharmaceuticals, Xiamen Kingdonway, Pharma Essentia, Space Biolog, ZMC, Biotechnology Limited, Yuxi Jankun and Haotian. Companies are adopting various strategies to expand their market share by launching new products in various forms including soft gels and tablets. These strategies will enhance their penetration in the ubiquinone market.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

This release was published on openPR.